Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors. | EBioMedicine | 2023 | 37924708 | PubTator, text mining | PubMed |
| The role of matrix stiffness in breast cancer progression: a review. | Front Oncol | 2023 | 37916166 | PubTator, text mining | PubMed |
| Philadelphia chromosome-negative myeloproliferative chronic neoplasms: is clonal hematopoiesis the main determinant of autoimmune and cardio-vascular manifestations? | Front Med (Lausanne) | 2023 | 37915324 | PubTator, text mining | PubMed |
| Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma. | Cancer Res Commun | 2023 | 37910143 | PubTator, text mining | PubMed |
| Efficacy and safety of Panax notoginseng saponins (Xuesaitong) for patients with acute ischemic stroke: a systematic review and meta-analysis of randomized controlled trials. | Front Pharmacol | 2023 | 37908976 | PubTator, text mining | PubMed |
| MicroRNA-30a-3p: a potential noncoding RNA target for the treatment of arteriosclerosis obliterans. | Aging (Albany NY) | 2023 | 37899171 | PubTator, text mining | PubMed |
| Analysis of miRNAs in Osteogenesis imperfecta Caused by Mutations in COL1A1 and COL1A2: Insights into Molecular Mechanisms and Potential Therapeutic Targets. | Pharmaceuticals (Basel) | 2023 | 37895885 | PubTator, text mining | PubMed |
| Oncomeric Profiles of microRNAs as New Therapeutic Targets for Treatment of Ewing's Sarcoma: A Composite Review. | Genes (Basel) | 2023 | 37895198 | PubTator, text mining | PubMed |
| Integrated Meta-Omics Analysis Unveils the Pathways Modulating Tumorigenesis and Proliferation in High-Grade Meningioma. | Cells | 2023 | 37887327 | PubTator, text mining | PubMed |
| The pseudoenzyme ADPRHL1 affects cardiac function by regulating the ROCK pathway. | Stem Cell Res Ther | 2023 | 37880701 | PubTator, text mining | PubMed |
| Harnessing mechanical cues in the cellular microenvironment for bone regeneration. | Front Physiol | 2023 | 37877097 | PubTator, text mining | PubMed |
| HMGN2 and Histone H1.2: potential targets of a novel probiotic mixture for seasonal allergic rhinitis. | Front Microbiol | 2023 | 37869664 | PubTator, text mining | PubMed |
| Function of GSK‑3 signaling in spinal cord injury (Review). | Exp Ther Med | 2023 | 37869638 | PubTator, text mining | PubMed |
| Hottest topics in hematopoietic stem cell transplantation: a summary from the 8th International Transplant and Cellular Therapy Course. | Clin Hematol Int | 2023 | 37869470 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals molecular mechanisms of lymphocystis formation caused by lymphocystis disease virus infection in flounder (Paralichthys olivaceus). | Front Immunol | 2023 | 37868974 | PubTator, text mining | PubMed |
| Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-β-catenin signaling axis and static & dynamic dual roles. | Mol Med | 2023 | 37864185 | PubTator, text mining | PubMed |
| Post-thaw application of ROCK-inhibitors increases cryopreserved T-cell yield. | RSC Med Chem | 2023 | 37859712 | PubTator, text mining | PubMed |
| CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells. | Sci Adv | 2023 | 37851808 | PubTator, text mining | PubMed |
| Comprehensive analysis of serum exosome-derived lncRNAs and mRNAs from patients with rheumatoid arthritis. | Arthritis Res Ther | 2023 | 37845777 | PubTator, text mining | PubMed |
| Proteomic analysis of lysine 2-hydroxyisobutyryl in SLE reveals protein modification alteration in complement and coagulation cascades and platelet activation Pathways. | BMC Med Genomics | 2023 | 37845672 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=17